509 Prospective Surveillance and Treatment of De Novo Donor Specific Antibodies after Lung Transplantation Ameliorates 1-Year Risk of BOS

Autor: Ainge Allen, H.W., Havryk, A.P., Malouf, M.A., Plit, M., Benden, C., Watson, N., Glanville, A.R.
Zdroj: In Journal of Heart and Lung Transplantation April 2012 31(4) Supplement:S178-S178
Databáze: ScienceDirect